APA (7th ed.) Citation

Jr, R. J., F, A., CN, K., G, C., LC, P., & E, D. (2024). QuantiFERON-CMV as a Predictor of CMV Events During Preemptive Therapy in CMV-seropositive Kidney Transplant Recipients. Transplantation, 108(4), 985. https://doi.org/10.1097/TP.0000000000004870

Chicago Style (17th ed.) Citation

Jr, Reusing JO, Agena F, Kotton CN, Campana G, Pierrotti LC, and David-Neto E. "QuantiFERON-CMV as a Predictor of CMV Events During Preemptive Therapy in CMV-seropositive Kidney Transplant Recipients." Transplantation 108, no. 4 (2024): 985. https://doi.org/10.1097/TP.0000000000004870.

MLA (9th ed.) Citation

Jr, Reusing JO, et al. "QuantiFERON-CMV as a Predictor of CMV Events During Preemptive Therapy in CMV-seropositive Kidney Transplant Recipients." Transplantation, vol. 108, no. 4, 2024, p. 985, https://doi.org/10.1097/TP.0000000000004870.